🔎 Trials Near Me

Home › Oligodendroglioma

Oligodendroglioma clinical trials recruiting in the U.S.

15 studies for Oligodendroglioma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

RecruitingPhase 1
Ages 19 and older · All sexes · Updated Sep 14, 2026 · NCT05698524

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

RecruitingPhase 1/2
Ages 2 to 24 · All sexes · Updated Sep 11, 2026 · NCT04923126

FearLess in NeuroOncology

Recruiting
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06989086

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388

Study of Olutasidenib and Temozolomide in HGG

RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT04623931

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT07468136

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

RecruitingPhase 1
Ages 18 to 89 · All sexes · Updated May 27, 2026 · NCT06254326

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 21, 2026 · NCT07462507

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 20, 2026 · NCT05345002

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT04541082

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

RecruitingPhase 1/2Healthy volunteers welcome
Ages 1 to 21 · All sexes · Updated Dec 8, 2025 · NCT05956821

HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)

Recruiting
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT06930846

Implantable Microdevice In Primary Brain Tumors

RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jul 23, 2025 · NCT04135807

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.